463-03-003 ISMRM Abstract

Macrovascular Arterial Transit Time from 4D ASL-MRA: A Novel Hemodynamic Biomarker in Intracranial Steno-Occlusive Disease

Primary: Neuro - Blood Vessels

Secondary: Neuro - Stroke and Cerebrovascular Disorders

463-03-003 · Metabolic Parameters in Stroke · Tuesday, 12 May, 1:40 PM–2:35 PM · Digital Posters Row D

Keywords: Arterial spin labeling Macrovascular arterial transit time 4DMRA Intracranial steno-occlusive disease

Accepted

Quinten Deckers ^1,2, Simone M Uniken Venema³, Pieter T Deckers³, Kees P Braun⁴, Bart van der Zwan⁴, Jeroen Siero^1,2,3, Alex A Bhogal^1,2

¹Division Imaging and Oncology, UMC Utrecht, Utrecht, Netherlands

²Translational Neuroimaging group, Center for Image Sciences, UMC Utrecht, Utrecht, Netherlands

³Department of Radiology and Nuclear Medicine, UMC Utrecht, Utrecht, Netherlands

⁴Brain Center, Department of Neurology and Neurosurgery, UMC Utrecht, Utrecht, Netherlands

Presenting Author: Quinten Deckers

Synopsis

Motivation:

Goals:

Approach:

Results:

Full abstract & presentation

The full text, figures, and any recorded presentation for this abstract are not shown here. Log in if you are a member or registered attendee with access.

Full abstracts, figures, and presentations for Cape Town - 2026 ISMRM-ISMRT Annual Meeting and Exhibition are available to registered attendees. This content becomes freely available to the public roughly two years after the meeting.

To request or purchase access, contact the ISMRM Central Office at info@ismrm.org.

References

1. 1. Canavero I, Vetrano IG, Zedde M, Pascarella R, Gatti L, Acerbi F, Nava S, Ferroli P, Parati EA, Bersano A. Clinical management of Moyamoya patients. J Clin Med. 2021;10(16):3628. doi:10.3390/jcm10163628 [doi]

2. 2. Ge P, Zhang Q, Ye X, et al. Digital subtraction angiographic characteristics of progression of moyamoya disease 6 months prior to surgical revascularisation. Stroke and Vascular Neurology. 2020;5(1):97-102. doi:10.1136/svn-2019-000316 [doi]

3. 3. Fan AP, Khalighi MM, Guo J, Ishii Y, Rosenberg J, Wardak M, Park JH, Shen B, Holley D, Gandhi H, et al. Identifying hypoperfusion in Moyamoya disease with arterial spin labeling and an [(15)O]-water positron emission tomography/magnetic resonance imaging normative database. Stroke. 2019;50(2):373–380.

4. 4. Zhao MY, Fan AP, Chen DYT, Ishii Y, Khalighi MM, Moseley M, Steinberg GK, Zaharchuk G. Using arterial spin labeling to measure cerebrovascular reactivity in Moyamoya disease: insights from simultaneous PET/MRI. J Cereb Blood Flow Metab. 2022;42(8):1493–1506.

5. 5. Takata K, Kimura H, Ishida S, Isozaki M, Higashino Y, Kikuta KI, Okazawa H, Tsujikawa T. Assessment of arterial transit time and cerebrovascular reactivity in Moyamoya disease by simultaneous PET/MRI. Diagnostics (Basel). 2023;13(1):1–13.

6. 6. Togao O, Obara M, Yamashita K, et al. Hybrid Multidelay PCASL acquired with Time‐Encoded and Variable‐TR schemes for the assessment of cerebral perfusion in Moyamoya disease. NMR in Biomedicine. 2025;38(7). doi:10.1002/nbm.70069 [doi]

7. 7. Buxton RB, Frank LR, Wong EC, Siewert B, Warach S, Edelman RR. A general kinetic model for quantitative perfusion imaging with arterial spin labeling. Magnetic Resonance in Medicine. 1998;40(3):383-396. doi:10.1002/mrm.1910400308 [doi]

8. 8. Bhogal AA, Venema SMU, Deckers PT, et al. A novel model to quantify blood transit time in cerebral arteries using ASL-based 4D magnetic resonance angiography with example clinical application in moyamoya disease. Journal of Cerebral Blood Flow & Metabolism. February 2025. doi:10.1177/0271678x251321640 [doi]

9. 9. Bates D, Mächler M, Bolker B, Walker S. Fitting linear mixed-effects models using lme4. J Stat Softw. 2015;67(1):1–48. doi:10.18637/jss.v067.i01 [doi]

Cite this abstract

http://echo.ismrm.org/p/ISMRM2026/463-03-003